Windlas Biotech Ltd Share Price Today - Windlas Biotech Ltd Stock Price Live NSE/BSE

Windlas Biotech Ltd

NSE: WINDLAS BSE: 543329

₹797.80

(0.76)%

Fri, 13 Feb 2026, 00:05 am

MTF 5xInvest in Windlas Biotech Ltd with 5x Leverage Buy with MTF

Market Cap16.74B

PE Ratio25.34

Dividend0.73

Health Technology

Pharmaceuticals: Major

24.5K

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1679.96
Net Profit
60.99
P/B
4.31
Sector P/E
32.61
P/E
35.78
EV/EBITDA
19.61
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
12.78
ROCE (Industry)
15.36
RONW (Industry)
13.46
ROE
12.76
ROCE
16.87
Debt/Equity
0.04
EPS (TTM)
31.67
Dividend Yield
0.72
Book Value
253.39
Interest Cover
19.21

Analysis

No Result Found

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	61.99	61.99	62.34	62.34	62.51
FII	0.93	1.11	1.44	1.52	1.55
DII	11.44	11.43	11.21	10.89	10.26
Public	25.64	25.47	25.01	25.25	25.68
Government	0	0	0	0	0

Technical Analysis

RSI

46.14

MACD

8.25

50 DMA

797.23

200 DMA

897.84

Support and Resistance

Type	R1	R2	R3	PP	S1	S2	S3
Classic	1274.13	1059.43	954.17	844.73	739.47	630.03	415.33
Fibonacci	1059.43	977.42	926.75	844.73	762.72	712.05	630.03
Camarilla	907.94	888.26	868.58	844.73	829.22	809.54	789.86

Pivots Level: Classic

+429.40

1274.13

+214.70

1059.43

+109.43

954.17

844.73

Pivot Point

LTP: 797.80

-105.27

739.47

-214.70

630.03

-429.40

415.33

Moving Average

SMAEMA

Period

Value

10-EMA
827.31
20-EMA
821.99
30-EMA
817.16
50-EMA
818.15
100-EMA
841.30
200-EMA
868.79

Announcement Date	Purpose	Action	Ex Date
05 Feb 2026	board-meetings	Quarterly Results
06 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
04 Jul 2025	agm
22 May 2025	dividend	₹5.80 Dividend /Share	21 Jul 2025
02 Sept 2024	agm
20 May 2024	dividend	₹5.50 Dividend /Share	17 Sept 2024
16 Aug 2023	agm
05 May 2023	dividend	₹4.00 Dividend /Share	05 Sept 2023
08 Nov 2022	buyback
25 Aug 2022	agm

Windlas Biotech Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Cipla Ltd

Divis Laboratories Ltd

About Windlas Biotech Ltd

Windlas Biotech is engaged in manufacturing and trading of pharmaceutical products.

Industry

Pharmaceuticals - Indian - Formulations

Founded

2001

Headquarters

CEO

Vivek Dhariwal

Employees

Contact

Website

http://www.windlasbiotech.com

grievance@windlasbiotech.com

Phone

91-135-6608000

Location

40/1 Mohabewala Industrial, Area, Dehradun, Uttarakhand, 248110

Year	History
2016	The Company was converted into a private limited company. A fresh certificate of incorporation consequent upon conversion and change of name to Windlas Biotech Private Limited was granted.
2017	Revenues crossed Rs. 3,000 million for the FY 2016-17.
2018	The Company launched its first product in the United States from Dehradun Plant – IV. The Company commenced operations at Dehradun Plant – III.
2021	The Company was converted from a private limited company to a public limited company. The name of the Company was changed to Windlas Biotech Limited. A fresh certificate of incorporation was granted by the RoC. Approval of Scheme of Amalgamation of the erstwhile subsidiary, Windlas Healthcare, with and into the Company was obtained.
2022	The Company received a certificate of Good Manufacturing Practices (GMP) from SAHPRA.

Client Name	Order Side	QTY	Avg Price	Date
AJAY KUMAR AGGARWAL	Buy	144995	787.42	20 Feb 2025
SAMVITTI CAPITAL PRIVATE LIMITED ACTIVE ALPHA MULTICAP	Sell	115374	683.49	19 Feb 2025
GRAVITON RESEARCH CAPITAL LLP	Sell	110668	564.94	01 Mar 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	110668	565.96	01 Mar 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	135363	522.39	08 Feb 2024
GRAVITON RESEARCH CAPITAL LLP	Sell	135363	522.27	08 Feb 2024
JAINAM BROKING LIMITED	Sell	96128	520.7	02 Jan 2024
JAINAM BROKING LIMITED	Buy	150028	511.5	02 Jan 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	409737	517.17	02 Jan 2024
GRAVITON RESEARCH CAPITAL LLP	Sell	409737	517.5	02 Jan 2024

windlas biotech limited News

Windlas Biotech Faces Manufacturing Suspension Notice

Windlas Biotech receives show cause notice from Uttarakhand FDA for temporary suspension of codeine-containing cough syrup manufacturing. Affected product line contributed Rs. 55.21 crore to revenue.

10 Feb 2026

stocks

Windlas Biotech Re-appoints Three Key Directors

Windlas Biotech Limited announces re-appointment of three directors including Whole-time Director Ashok Kumar Windlass and Independent Directors Vivek Dhariwal and Gaurav Gulati for five-year terms.

05 Feb 2026

stocks

Windlas Biotech dissolves US subsidiary

Windlas Biotech Limited's board approves dissolution of non-operating wholly owned subsidiary Windlas Inc. USA with zero turnover and negative net worth of USD -1923.10.

05 Feb 2026

stocks

Windlas Biotech Q3 Revenue Rises 18% to ₹2.3B

Windlas Biotech reported Q3 consolidated revenue of ₹2.30 billion, up from ₹1.95 billion year-on-year, though net profit declined slightly to ₹150 million from ₹155 million in the same period last year.

05 Feb 2026

co actions results

Windlas Biotech Board Meet Set for Feb 5, 2026

Windlas Biotech has scheduled a board meeting on February 5, 2026, to consider and approve Q3FY26 unaudited financial results for quarter and nine months ended December 31, 2025.

28 Jan 2026

co actions results

Showing 1–5 of 12

Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800